Vector‐mediated release of GABA attenuates pain‐related behaviors and reduces Na V 1.7 in DRG neurons
dc.contributor.author | Chattopadhyay, Munmun | en_US |
dc.contributor.author | Mata, Marina | en_US |
dc.contributor.author | Finkl, David J. | en_US |
dc.date.accessioned | 2012-03-16T16:01:42Z | |
dc.date.available | 2012-12-03T21:17:33Z | en_US |
dc.date.issued | 2011-10 | en_US |
dc.identifier.citation | Chattopadhyay, Munmun; Mata, Marina; Finkl, David J. (2011). "Vector‐mediated release of GABA attenuates pain‐related behaviors and reduces Na V 1.7 in DRG neurons." European Journal of Pain 15(9). <http://hdl.handle.net/2027.42/90401> | en_US |
dc.identifier.issn | 1090-3801 | en_US |
dc.identifier.issn | 1532-2149 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/90401 | |
dc.description.abstract | Pain is a common and debilitating accompaniment of neuropathy that occurs as a complication of diabetes. In the current study, we examined the effect of continuous release of gamma amino butyric acid (GABA), achieved by gene transfer of glutamic acid decarboxylase (GAD67) to dorsal root ganglia (DRG) in vivo using a non‐replicating herpes simplex virus (HSV)‐based vector (vG) in a rat model of painful diabetic neuropathy (PDN). Subcutaneous inoculation of vG reduced mechanical hyperalgesia, thermal hyperalgesia and cold allodynia in rats with PDN. Continuous release of GABA from vector transduced cells in vivo prevented the increase in the voltage‐gated sodium channel isoform 1.7 (Na V 1.7) protein that is characteristic of PDN. In vitro , infection of primary DRG neurons with vG prevented the increase in Na V 1.7 resulting from exposure to hyperglycemia. The effect of vector‐mediated GABA on Na V 1.7 levels in vitro was blocked by phaclofen but not by bicuculline, a GABA B receptor effect that was blocked by pertussis toxin‐(PTX) interference with Gα( i/o ) function. Taken in conjunction with our previous observation that continuous activation of delta opioid receptors by vector‐mediated release of enkephalin also prevents the increase in Na V 1.7 in DRG exposed to hyperglycemia in vitro or in vivo , the observations in this report suggest a novel common mechanism through which activation of G protein coupled receptors (GPCR) in DRG neurons regulate the phenotype of the primary afferent. | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Pain | en_US |
dc.subject.other | Painful Diabetic Neuropathy | en_US |
dc.subject.other | Diabetes | en_US |
dc.subject.other | Voltage‐Gated Sodium Channels | en_US |
dc.subject.other | Gene Transfer | en_US |
dc.subject.other | Gene Therapy | en_US |
dc.title | Vector‐mediated release of GABA attenuates pain‐related behaviors and reduces Na V 1.7 in DRG neurons | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Anesthesiology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Neurology, University of Michigan and VA Ann Arbor Healthcare System, Ann Arbor, MI, USA | en_US |
dc.identifier.pmid | 21486703 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/90401/1/j.ejpain.2011.03.007.pdf | |
dc.identifier.doi | 10.1016/j.ejpain.2011.03.007 | en_US |
dc.identifier.source | European Journal of Pain | en_US |
dc.identifier.citedreference | K.A. Moore T. Kohno L.A. Karchewski J. Scholz H. Baba C.J. Woolf Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 22 2002 6724 – 6731. | en_US |
dc.identifier.citedreference | J. Lai J.C. Hunter F. Porreca The role of voltage‐gated sodium channels in neuropathic pain. Curr Opin Neurobiol 13 2003 291 – 297. | en_US |
dc.identifier.citedreference | B. Lee J. Kim S.J. Kim H. Lee J.W. Chang Constitutive GABA expression via a recombinant adeno‐associated virus consistently attenuates neuropathic pain. Biochem Biophys Res Commun 357 2007 971 – 976. | en_US |
dc.identifier.citedreference | J. Liu C. Tai W.C. de Groat X.M. Peng M. Mata D.J. Fink Release of GABA from sensory neurons transduced with a GAD67‐expressing vector occurs by non‐vesicular mechanisms. Brain Res 1073–1074 2006 297 – 304. | en_US |
dc.identifier.citedreference | J. Liu D. Wolfe S. Hao S. Huang J.C. Glorioso M. Mata et al. Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol Ther 10 2004 57 – 66. | en_US |
dc.identifier.citedreference | M. Malcangio N.G. Bowery Possible therapeutic application of GABAB receptor agonists and antagonists. Clin Neuropharmacol 18 1995 285 – 305. | en_US |
dc.identifier.citedreference | M. Malcangio D.R. Tomlinson A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain 76 1998 151 – 157. | en_US |
dc.identifier.citedreference | P.W. Mantyh S.P. Hunt Setting the tone: superficial dorsal horn projection neurons regulate pain sensitivity. Trends Neurosci 27 2004 582 – 584. | en_US |
dc.identifier.citedreference | M. Mata S. Hao D.J. Fink Applications of gene therapy to the treatment of chronic pain. Curr Gene Ther 8 2008 42 – 48. | en_US |
dc.identifier.citedreference | S. Misawa K. Sakurai K. Shibuya S. Isose K. Kanai J. Ogino et al. Neuropathic pain is associated with increased nodal persistent Na(+) currents in human diabetic neuropathy. J Peripher Nerv Syst 14 2009 279 – 284. | en_US |
dc.identifier.citedreference | J. Ong N.L. Harrison R.G. Hall J.L. Barker G.A. Johnston D.I. Kerr 3‐Aminopropanephosphinic acid is a potent agonist at peripheral and central presynaptic GABAB receptors. Brain Res 526 1990 138 – 142. | en_US |
dc.identifier.citedreference | L.O. Randall J.J. Sellito A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111 1957 409 – 419. | en_US |
dc.identifier.citedreference | J.M. Rho S.D. Donevan M.A. Rogawski Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons. J Physiol 497 ( Pt 2 ) 1996 509 – 522. | en_US |
dc.identifier.citedreference | T.N. Robinson A.J. Cross A.R. Green J.M. Toczek B.R. Boar Effects of the putative antagonists phaclofen and delta‐aminovaleric acid on GABAB receptor biochemistry. Br J Pharmacol 98 1989 833 – 840. | en_US |
dc.identifier.citedreference | I. Shibuya S. Kongsamut W.W. Douglas Effectiveness of GABAB antagonists in inhibiting baclofen‐induced reductions in cytosolic free Ca concentration in isolated melanotrophs of rat. Br J Pharmacol 105 1992 893 – 898. | en_US |
dc.identifier.citedreference | G.D. Smith S.M. Harrison P.J. Birch P.J. Elliott M. Malcangio N.G. Bowery Increased sensitivity to the antinociceptive activity of (+/−)‐baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia. Neuropharmacology 33 1994 1103 – 1108. | en_US |
dc.identifier.citedreference | I. Sukhotinsky E. Ben‐Dor P. Raber M. Devor Key role of the dorsal root ganglion in neuropathic tactile hypersensibility. Eur J Pain 8 2004 135 – 143. | en_US |
dc.identifier.citedreference | M. Tavakoli M. Mojaddidi H. Fadavi R.A. Malik Pathophysiology and treatment of painful diabetic neuropathy. Curr Pain Headache Rep 12 2008 192 – 197. | en_US |
dc.identifier.citedreference | T.D. Wilson‐Gerwing C.L. Stucky G.W. McComb V.M. Verge Neurotrophin‐3 significantly reduces sodium channel expression linked to neuropathic pain states. Exp Neurol 213 2008 303 – 314. | en_US |
dc.identifier.citedreference | D. Wolfe W.F. Goins M. Yamada S. Moriuchi D.M. Krisky T.J. Oligino et al. Engineering herpes simplex virus vectors for CNS applications. Exp Neurol 159 1999 34 – 46. | en_US |
dc.identifier.citedreference | D. Wolfe S. Hao J. Hu R. Srinivasan J. Goss M. Mata et al. Engineering an endomorphin‐2 gene for use in neuropathic pain therapy. Pain 133 2007 29 – 38. | en_US |
dc.identifier.citedreference | D. Wolfe M. Mata D.J. Fink A human trial of HSV‐mediated gene transfer for the treatment of chronic pain. Gene Ther 16 2009 455 – 460. | en_US |
dc.identifier.citedreference | X.L. Yang Characterization of receptors for glutamate and GABA in retinal neurons. Prog Neurobiol 73 2004 127 – 150. | en_US |
dc.identifier.citedreference | W. Zhang L.Y. Liu T.L. Xu Reduced potassium‐chloride co‐transporter expression in spinal cord dorsal horn neurons contributes to inflammatory pain hypersensitivity in rats. Neuroscience 152 2008 502 – 510. | en_US |
dc.identifier.citedreference | R. Baron Peripheral neuropathic pain: from mechanisms to symptoms. Clin J Pain 16 2000 S12 – 20. | en_US |
dc.identifier.citedreference | J.A. Black S. Liu M. Tanaka T.R. Cummins S.G. Waxman Changes in the expression of tetrodotoxin‐sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain 108 2004 237 – 247. | en_US |
dc.identifier.citedreference | J.M. Castro‐Lopes M. Malcangio B.H. Pan N.G. Bowery Complex changes of GABAA and GABAB receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy. Brain Res 679 1995 289 – 297. | en_US |
dc.identifier.citedreference | J.M. Castro‐Lopes I. Tavares A. Coimbra GABA decreases in the spinal cord dorsal horn after peripheral neurectomy. Brain Res 620 1993 287 – 291. | en_US |
dc.identifier.citedreference | M. Chattopadhyay J. Goss D. Lacomis W. Goins J.C. Glorioso M. Mata et al. Protective effect of HSV‐mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals. Eur J Neurosci 17 2003 732 – 740. | en_US |
dc.identifier.citedreference | M. Chattopadhyay M. Mata D.J. Fink Continuous delta opioid receptor activation reduces neuronal voltage gated sodium channel (Na V 1.7) levels through activation of protein kinase C in painful diabetic neuropathy. J Neurosci 28 2008 6652 – 6658. | en_US |
dc.identifier.citedreference | J.A. Coull D. Boudreau K. Bachand S.A. Prescott F. Nault A. Sik et al. Trans‐synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 424 2003 938 – 942. | en_US |
dc.identifier.citedreference | J.J. Cox F. Reimann A.K. Nicholas G. Thornton E. Roberts K. Springell et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444 2006 894 – 898. | en_US |
dc.identifier.citedreference | T.R. Cummins P.L. Sheets S.G. Waxman The roles of sodium channels in nociception: implications for mechanisms of pain. Pain 131 2007 243 – 257. | en_US |
dc.identifier.citedreference | M. Devor Sodium channels and mechanisms of neuropathic pain. J Pain 7 2006 S3 – S12. | en_US |
dc.identifier.citedreference | S.D. Dib‐Hajj T.R. Cummins J.A. Black S.G. Waxman From genes to pain: Na v 1.7 and human pain disorders. Trends Neurosci 30 2007 555 – 563. | en_US |
dc.identifier.citedreference | D.M. Dirig T.L. Yaksh Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat‐formalin model. J Pharmacol Exp Ther 275 1995 219 – 227. | en_US |
dc.identifier.citedreference | J.P. Drenth S.G. Waxman Mutations in sodium‐channel gene SCN9A cause a spectrum of human genetic pain disorders. J Clin Invest 117 2007 3603 – 3609. | en_US |
dc.identifier.citedreference | M.J. Eaton J.A. Plunkett S. Karmally M.A. Martinez K. Montanez Changes in GAD‐ and GABA‐immunoreactivity in the spinal dorsal horn after peripheral nerve injury and promotion of recovery by lumbar transplant of immortalized serotonergic precursors. J Chem Neuroanat 16 1998 57 – 72. | en_US |
dc.identifier.citedreference | J. Ekberg D.J. Adams Neuronal voltage‐gated sodium channel subtypes: key roles in inflammatory and neuropathic pain. Int J Biochem Cell Biol 38 2006 2005 – 2010. | en_US |
dc.identifier.citedreference | M.P. Engle M. Gassman K.T. Sykes B. Bettler D.L. Hammond Spinal nerve ligation does not alter the expression or function of GABA(B) receptors in spinal cord and dorsal root ganglia of the rat. Neuroscience 138 2006 1277 – 1287. | en_US |
dc.identifier.citedreference | N.B. Finnerup S.H. Sindrup T.S. Jensen The evidence for pharmacological treatment of neuropathic pain. Pain 150 2010 573 – 581. | en_US |
dc.identifier.citedreference | J.C. Glorioso D.J. Fink Herpes vector‐mediated gene transfer in treatment of diseases of the nervous system. Annu Rev Microbiol 58 2004 253 – 271. | en_US |
dc.identifier.citedreference | J.R. Goss C.F. Harley M. Mata M.E. O'Malley W.F. Goins X.‐P. Hu et al. Herpes vector‐mediated expression of proenkephalin reduces pain‐related behavior in a model of bone cancer pain. Ann Neurol 52 2002 662 – 665. | en_US |
dc.identifier.citedreference | J.R. Goss M. Mata W.F. Goins H.H. Wu J.C. Glorioso D.J. Fink Antinociceptive effect of a genomic herpes simplex virus‐based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther 8 2001 551 – 556. | en_US |
dc.identifier.citedreference | S. Hao M. Mata W. Goins J.C. Glorioso D.J. Fink Transgene‐mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect. Pain 102 2003 135 – 142. | en_US |
dc.identifier.citedreference | S. Hao M. Mata D. Wolfe J.C. Glorioso D.J. Fink Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Ann Neurol 57 2005 914 – 918. | en_US |
dc.identifier.citedreference | S. Hao D. Wolfe J.C. Glorioso M. Mata D.J. Fink Effects of transgene‐mediated endomorphin‐2 in inflammatory pain. Eur J Pain 13 2009 380 – 386. | en_US |
dc.identifier.citedreference | K. Hargreaves R. Dubner F. Brown C. Flores J. Joris A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 1988 77 – 88. | en_US |
dc.identifier.citedreference | S. Hong T.J. Morrow P.E. Paulson L.L. Isom J.W. Wiley Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin‐sensitive and ‐resistant sodium channels in dorsal root ganglion neurons in the rat. J Biol Chem 279 2004 29341 – 29350. | en_US |
dc.identifier.citedreference | S. Hong J.W. Wiley Altered expression and function of sodium channels in large DRG neurons and myelinated A‐fibers in early diabetic neuropathy in the rat. Biochem Biophys Res Commun 339 2006 652 – 660. | en_US |
dc.identifier.citedreference | J.H. Hwang T.L. Yaksh The effect of spinal GABA receptor agonists on tactile allodynia in a surgically‐induced neuropathic pain model in the rat. Pain 70 1997 15 – 22. | en_US |
dc.identifier.citedreference | T. Ibuki A.T. Hama X.T. Wang G.D. Pappas J. Sagen Loss of GABA‐immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neuroscience 76 1997 845 – 858. | en_US |
dc.identifier.citedreference | C.G. Jolivalt C.A. Lee K.M. Ramos N.A. Calcutt Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium‐chloride co‐transporters. Pain 140 2008 48 – 57. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.